CN112695047B - Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum - Google Patents

Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum Download PDF

Info

Publication number
CN112695047B
CN112695047B CN202110031208.XA CN202110031208A CN112695047B CN 112695047 B CN112695047 B CN 112695047B CN 202110031208 A CN202110031208 A CN 202110031208A CN 112695047 B CN112695047 B CN 112695047B
Authority
CN
China
Prior art keywords
ala
val
leu
gly
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110031208.XA
Other languages
Chinese (zh)
Other versions
CN112695047A (en
Inventor
范勇
李福利
姜尔颖
丁晓婷
师晓艺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao High Energy Hecheng Biotechnology Co ltd
Original Assignee
Qingdao Institute of Bioenergy and Bioprocess Technology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Institute of Bioenergy and Bioprocess Technology of CAS filed Critical Qingdao Institute of Bioenergy and Bioprocess Technology of CAS
Priority to CN202110031208.XA priority Critical patent/CN112695047B/en
Publication of CN112695047A publication Critical patent/CN112695047A/en
Application granted granted Critical
Publication of CN112695047B publication Critical patent/CN112695047B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1229Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/04Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • C12Y207/04027[Pyruvate, phosphate dikinase]-phosphate phosphotransferase (2.7.4.27)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a method for producing fucoxanthin by a mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum, in particular to a method for optimizing algae preference codons of an original CyPPDK gene to obtain a new CyPPDK gene, wherein the nucleotide sequence is shown as SEQ ID No. 7; the constructed shuttle expression vector is named pPha-fcp-PPDK; introducing the cells into a host algae cell Phaeodactylum tricornutum by an electrotransformation mode, and screening a transformant to obtain a transgenic phaeodactylum tricornutum strain over-expressing pyruvate phosphate dikinase; compared with the non-optimized transformant, the optimized transformant carrying out phosphorylation sites on CyPPDK gene has the advantages that the biomass accumulation is improved by 33.3 percent, the content of EPA in oil is improved by 11.5 percent, and the yield of fucoxanthin is improved by 21.2 percent.

Description

Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum
Technical Field
The invention relates to a method for producing fucoxanthin by expressing exogenous pyruvate phosphate dikinase overexpression mutant strains in phaeodactylum tricornutum, belonging to the technical field of biological engineering.
Background
Phaeodactylum tricornutum belongs to the phylum Diatom, class Luciformes, order Phaeodactylum, genus Phaeodactylum, is an important aquatic food, and is rich in active substances such as EPA (Eicosapentaenoic acid) and Fucoxanthin (Fucoxanthin). Fucoxanthin, also known as fucoxanthin, is an oxygen-containing derivative of carotene having one allene bond, one epoxide, and one conjugated carbonyl group on its molecular polyene chain, and is a polar carotenoid. Fucoxanthin has various biological activities, and has effects of promoting metabolism, increasing metabolism of triglyceride and cholesterol, resisting inflammation, tumor, obesity and oxidation. The phaeodactylum tricornutum has high propagation speed, can be cultured in a photoreactor, and has high content of unsaturated fatty acid and fucoxanthin in cells, so that the improvement of the phaeodactylum tricornutum to improve the accumulation of the fucoxanthin and the polyunsaturated fatty acid has important significance.
C4C contained in plant4Related enzymes in the pathway can promote the conversion of CO into mesophyll cells2With C4The compound is fixed, so that the plant can utilize limited water and low-concentration CO under the conditions of strong light, high temperature, drought and other adverse conditions and closed leaf pores2And high photosynthetic efficiency is kept. Currently, a series of C's are screened and identified in Phaeodactylum tricornutum4A gene related to the pathway, wherein Pyruvate Phosphate Dikinase (PPDK) is C4A very important rate-limiting enzyme in the photosynthetic pathway catalyzes pyruvate and ATP to produce phosphoenolpyruvate. And phosphoenolpyruvate can bind CO2Thus the step is C4The photosynthetic pathway provides an important carbon skeleton. In plants, two forms of PPDK were detected. One is Chloroplast localized PPDK (Chloroplast PPDK), and the other is Cytoplasmic PPDK (Cytoplastic PPDK). CyPPDK is generally expressed in non-photosynthetic tissues of plants, such as roots and seeds. Some studies found C3The PPDK gene overexpression in the plant generates obvious response to some adversity stresses, and the tolerance of the plant to the adversity stresses is improved.
Disclosure of Invention
Aiming at the problem of low fucoxanthin yield in the existing large-scale culture of phaeodactylum tricornutum, the invention aims to use the genetic transformation technology to convert exogenous C4The CyPPDK of the pathway is over-expressed in phaeodactylum tricornutum, and the phosphorylation of the enzyme activity is regulated and controlledThe site optimization improves the enzyme catalysis level, promotes the carbon fixation efficiency of cells, and improves the accumulation of unsaturated fatty acid and fucoxanthin.
The inventor finds that the phaeodactylum tricornutum algae is extremely sensitive to temperature in the culture process, and the temperature rise greatly influences the culture and production of the phaeodactylum tricornutum algae in the seasonal variation process, so that the construction of the mutant algae species capable of tolerating higher temperature (more than 35 ℃ and less than 40 ℃) is helpful for the production of the phaeodactylum tricornutum algae. Therefore, the CyPPDK in the exogenous marine microalgae is further expressed in the phaeodactylum tricornutum through codon optimization and phosphorylation site optimization for the first time by a genetic transformation technology, and the growth rate and the accumulation amount of EPA and fucoxanthin of the transformation mutant strain at high temperature are obviously improved.
A method for constructing a mutant strain of overexpressed pyruvate phosphate dikinase in phaeodactylum tricornutum comprises the following steps:
(1) carrying out algae preference codon optimization on the original CyPPDK gene to obtain a new CyPPDK gene, wherein the nucleotide sequence is shown as SEQ ID No. 7;
(2) construction of overexpression vector of CyPPDK gene
Using plasmid pPha-T1 (figure 1) as a basic expression vector, using fcp-A as a promoter, inserting the PPDK gene obtained above into the downstream of the fcp-A promoter to construct a PPDK expression vector, using plasmid pPha-T1 as a template, and using primers pPha-BB-F/R to perform PCR amplification on a skeleton fragment required by the constructed vector; PCR amplifying PPDK gene segment by using the obtained PPDK gene as a template and using a primer CyPPDK-F/R; based on the overlapping region between the PPDK fragment and the vector backbone fragment, the fragments were ligated using a seamless ligase kit, and the constructed shuttle expression vector was named pPha-fcp-PPDK, and the primer sequences were as follows:
pPha-BB-F:aaggcgcactaacagaagcgtgctatcgaact SEQ ID NO.1;
pPha-BB-R:ttttcgcggcatcattcgaaacggcagacaaa SEQ ID NO.2;
CyPPDK-F:gtttcgaatgatgccgcgaaaagacaagtg SEQ ID NO.3;
CyPPDK-R:cacgcttctgttagtgcgccttgccattac SEQ ID NO.4。
the italicized bold portions of the sequence indicate the overlapping (over-lap) segments that need to be designed during vector construction using a seamless ligase.
(3) Preparation of transformant
Taking the expression vector pPha-fcp-PPDK constructed in the step (2) as a template, utilizing a primer Trans-F/R to perform PCR amplification on a PPDK gene and a linearized fragment of a resistance gene (figure 2), introducing the PPDK gene and the linearized fragment into a host algal cell Phaeodactylum tricornutum (Phaeodactylum tricornutum) cell in an electrotransformation way, and screening a transformant to obtain a Phaeodactylum tricornutum transgenic algal strain over-expressing pyruvate phosphate dikinase, wherein the sequence of the primer is as follows:
Trans-F:atttaggtgacactatagaaccaga SEQ ID NO.5
Trans-R:gcttatcgaaattaatacgactcactataggga SEQ ID NO.6。
preferably, the PCR reaction system in step (2) is as follows:
DNA template 0.5. mu.L, upstream primer 10. mu.M 1. mu.L, downstream primer 10. mu.M 1. mu.L, KAPA HiFi DNA polymerase 12.5. mu.L, ddH2O 10μL。
Further preferably, the PCR reaction conditions in step (2) are as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 98 ℃ for 20s, annealing at 15s, extension at 72 ℃ for 2000bp/min, repeating 35 cycles; extension at 72 ℃ for 5 min.
Preferably, the PCR reaction system in step (3) is as follows:
DNA template 0.5. mu.L, upstream primer 10. mu.M 1. mu.L, downstream primer 10. mu.M 1. mu.L, KAPA HiFi DNA polymerase 25. mu.L, ddH2O 22.5μL。
Further preferably, the PCR reaction conditions in step (3) are as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 98 ℃ for 20s, annealing at 15s, extension at 72 ℃ for 2000bp/min, repeating 35 cycles; extension at 72 ℃ for 5 min.
Preferably, in step (3), the host algal cells are cultured in f/2 liquid medium to logarithmic growth phase, and are collected by centrifugal concentration (3-5). times.10)8(ii) individual cells; using 375 (c)Washing 4-6 times with mM sorbitol, adding 3-5 μ g PPDK gene and linear fragment of resistance gene into the algae solution, mixing uniformly, and placing on ice for reaction for 10-60 minutes; adding the algae liquid after reaction into an electric rotating cup, and carrying out electric shock under the conditions of 500-1500V, 400-1000 omega and 25-100 muF; immediately transferring the electrically shocked algae liquid to 10mL of fresh f/2 culture medium, and recovering for 24-48 hours at room temperature in a dark place; centrifuging the recovered algae liquid for 1500g 5 minutes, discarding the supernatant, suspending the algae liquid in a proper amount of fresh culture medium, coating the algae liquid on an f/2 resistant plate containing 5-100 mu g/ml of bleomycin resistance, culturing the algae liquid in an illumination incubator, and selecting transformants after 6-12 weeks.
Preferably, the Kit Trans Direct Plant Tissue PCR Kit is used for extracting the genome of the transformant, then the Direct PCR amplification operation is carried out on the algae cells, and the positive clone is verified by PCR product sequencing.
The culture method of the transgenic algae strain comprises the following steps:
culturing the transgenic strain at 22 + -1 deg.C for 10 days under the condition of illumination of 50 μmol phosns m for the first 7 days-2·s-1The light intensity is 16h light, 8h dark, and the rest 3 days 24h light.
According to the present invention, preferably, in the above culture method, the transgenic algal strain is cultured in f/2 medium.
The transgenic algae strain is applied to producing fucoxanthin and/or EPA.
Use of pyruvate phosphate dikinase in diatom to increase production of fucoxanthin and/or EPA.
According to the invention, the nucleotide sequence of the coding gene of the pyruvate phosphate dikinase is shown as SEQ ID NO. 10.
According to the invention, the amino acid sequence of the pyruvate phosphate dikinase is shown as SEQ ID NO. 8.
Preferably according to the invention, the diatom is phaeodactylum tricornutum.
The invention constructs codon optimization and phosphorylation site optimization based on exogenous CyPPDK, and expresses in Phaeodactylum tricornutum to ensure that the Phaeodactylum tricornutum has cytoplasmNow C4The possibility of the pathway phenotypically increases the content of unsaturated fatty acids and fucoxanthin in the phaeodactylum tricornutum under high temperature conditions.
The invention has the beneficial effects
1. According to the invention, the exogenous CyPPDK gene is expressed in Phaeodactylum tricornutum, so that the growth rate of the transgenic algae is improved by 53%, the content of EPA in oil is improved by 25%, and the yield of fucoxanthin is improved by 36% compared with the growth rate of the wild algae under the high-temperature and high-light conditions in summer.
2. According to the invention, phosphorylation sites of CyPPDK genes are optimized, and compared with a CyPPDK transformant without optimized phosphorylation sites, the biomass accumulation of the CyPPDK transformant with optimized phosphorylation sites is improved by 33.3%, the content of EPA in oil is improved by 11.5%, and the yield of fucoxanthin is improved by 21.2%.
Drawings
FIG. 1 construction and linearization of pPha-fcp-PPDK expression vector;
FIG. 2 PCR validation of CyPPDK fragment in transformants;
FIG. 3 growth curves of UN-CyPPDK transformant, OP-CyPPDK and wild type algal strains;
FIG. 4 EPA contents of UN-CyPPDK transformant, OP-CyPPDK transformant and wild type algal strain;
FIG. 5 fucoxanthin contents of UN-CyPPDK transformant, OP-CyPPDK transformant and wild type algal strain;
FIG. 6 shows the growth curves of UN-CyPPDK transformant, OP-CyPPDK and wild strain under high temperature conditions;
FIG. 7 EPA contents of UN-CyPPDK transformant, OP-CyPPDK transformant and wild type algal strain under high temperature condition;
FIG. 8 shows the fucoxanthin contents of the UN-CyPPDK transformant, OP-CyPPDK transformant and wild type algal strains under high temperature conditions.
Detailed Description
The technical solutions of the present invention are further described below with reference to the following embodiments and the drawings of the specification, but the scope of the present invention is not limited thereto.
Source of biological material
Phaeodactylum tricornutum (Phaeodactylum tricornutum) purchased from microalgae germplasm pool of China oceanic university, number MACC/B228; plasmid pPha-T1 was constructed from public data of the database, GenBank: AF 219942.1; the PPDK gene was synthesized by Beijing Ongkogaku Biotechnology Co., Ltd after modifying a specific base according to the public data of the database (GenBank: EWM23135.1) and bioinformatics analysis.
Other sources of raw materials
The sea salt is Blue Treasure sea salt purchased from saline science and technology limited of Qingdao sea, and is a common commercial product.
The contents of the examples, which are not specified in specific conditions, were carried out under conventional conditions; the reagents or instruments used are not indicated by manufacturers, and are all common commercial products.
Algal Strain number Specification
OP-CyPPDK, mutant strain obtained by transformation of CyPPDK with optimized phosphorylation site
UN-CyPPDK, a mutant strain obtained by transforming non-phosphorylation site-optimized CyPPDK
WT, wild type algal strain
Example 1
Specific phosphorylation site prediction of the PPDK protein (GenBank: EWM23135.1) of exogenous Nannochloropsis sp was performed using Netphos, reference Blom N, Gamma Lift S, Brunak S.sequence and structure-based prediction of eukaryotic protein phosphorylation sites [ J ]. Journal of Molecular Biology,1999,294(5): 1351-62. 79(T) in the protein sequence in the analysis result; 93 (S); 165 (T); 190 (S); 193 (S); 246 (S); 251 (T); 256 (T); 290 (T); 312 (T); 334 (T); 336 (T); 340 (T); 386 (T); 482 (T); 531 (S); 550 (S); 609 (T); 652 (S); 669 (T); 734 (T); 741 (T); 815 (T); 876 (T); 880(S) etc. site is the major phosphorylation site, 290 (T); 312 (T); 334 (T); 531 (S); 550 (S); 652 (S); 669(T) is the major site of engineering we have selected, and preferably, 652(S) is modified by phosphorylation. We entrusted the gene synthesis company to construct PPDK phosphorylation site mutants, changed the 652 th serine (S) to alanine (A), performed suitable for Phaeodactylum tricornutum codon optimization, and confirmed the mutation base position by DNA sequencing.
A construction method of a CyPPDK transformant, and expression determination of growth and high value-added product yield of the CyPPDK transformant.
The construction method of the CyPPDK transformant comprises the following steps:
(1) codon optimization and phosphorylation site optimization of CyPPDK gene and construction of expression vector
The invention optimizes the preferential codons of the original CyPPDK gene of algae, the nucleotide sequence of the optimized CyPPDK gene is shown as SEQ ID NO.7, and the amino acid sequence is consistent with the original amino acid sequence and is shown as SEQ ID NO. 8.
Specific phosphorylation site prediction is carried out on CyPPDK protein by using NetPhos, and in an analysis result, serine at position 652 in a protein sequence is subjected to phosphorylation modification, and protein kinase can catalyze ATP to transfer phosphate groups of the ATP to serine sites. We entrusted the gene synthesis company to construct PPDK phosphorylation site mutants. Mutation of DNA base results in change of protein amino acid, the 652 th serine (S) in the mutant PPDK protein sequence is changed into alanine (A), and the mutant protein can be normally expressed in algae cells, and the amino acid sequence is shown as SEQ ID NO. 9.
The PPDK expression vector was constructed by inserting the PPDK gene obtained above downstream of the fcp-A promoter using pPha-T1 as a base expression vector. Taking the plasmid pPha-T1 as a template, and carrying out PCR amplification on a skeleton fragment required by the constructed vector by using a primer pPha-BB-F/R; the PPDK gene fragment is amplified by PCR by using the obtained PPDK gene as a template and using a primer CyPPDK-F/R, wherein the sequence of the primer is as follows, and the sequence is shown in a table 1:
TABLE 1
Figure BDA0002892183300000051
Figure BDA0002892183300000061
*The italicized bold part of the sequence is indicated in the vectorIn the body construction process, overlapping (over-lap) fragments that need to be designed for seamless ligase are used.
And (3) PCR reaction system:
TABLE 2
Figure BDA0002892183300000062
And (3) PCR reaction conditions:
TABLE 3
Figure BDA0002892183300000063
Based on the overlap region between PPDK fragment and vector backbone fragment, using a seamless ligase kit (
Figure BDA0002892183300000065
Basic Seamless Cloning and Assembly Kit, beijing holothurian limited organism, CU201) and the constructed shuttle expression vector was named pha-fcp-PPDK, as shown in fig. 1.
Connecting a reaction system:
TABLE 4
Figure BDA0002892183300000064
In a 10. mu.L reaction system, the amount of vector and DNA fragment added was 0.01 to 0.25pmol, and the molar ratio of vector to each fragment was 1: 2.
the connection reaction conditions are as follows: the reaction system is blown and beaten, mixed evenly and then placed at 50 ℃ for reaction for 15 minutes.
Electrotransformation of transformants
(1) Electric conversion
a. The expression vector pPha-fcp-PPDK constructed above is used as a template, primers Trans-F and Trans-R are used for PCR amplification to co-express PPDK gene and a linearized fragment of a resistance gene (figure 2), the linearized fragment is introduced into a host algal cell Phaeodactylum tricornutum (Phaeodactylum tricornutum) cell in an electrotransformation mode, a single-copy transformant strain is screened, and a Phaeodactylum tricornutum transgenic algal strain which overexpresses pyruvate phosphate dikinase is obtained, wherein the primer sequences are as follows, and are shown in Table 5:
TABLE 5
Trans-F atttaggtgacactatagaaccaga
Trans-R gcttatcgaaattaatacgactcactataggga
And (3) PCR reaction system:
TABLE 6
Figure BDA0002892183300000071
And (3) PCR reaction conditions:
TABLE 7
Figure BDA0002892183300000072
b. Culturing algae cells in f/2 liquid culture medium to logarithmic growth phase, centrifuging, concentrating and collecting (3-5) x 108And (4) cells.
c. Washing with 375mM sorbitol for 4-6 times, finally suspending with 100-200 mu L sorbitol, adding 3-5 mu g PPDK gene and linear fragment of resistance gene into the algae liquid, mixing uniformly, and placing on ice for reaction for 10-60 minutes.
d. Adding the algae liquid after reaction into an electric rotating cup, carrying out electric shock under the conditions of 500-1500V, 400-1000 omega and 25-100 muF, immediately transferring the algae liquid after electric shock into 10mL of fresh F/2 culture medium, and recovering for 24-48 hours in a dark place at room temperature;
e. centrifuging the recovered algae liquid for 1500g 5 minutes, discarding the supernatant, suspending the algae liquid in a proper amount of fresh culture medium, coating the algae liquid on a resistance plate containing 5-100 mu g/ml of bleomycin, culturing the algae liquid in an illumination incubator, and selecting transformants after 6-12 weeks.
(3) Screening of transformant
The transformants were picked up in a fresh f/2 liquid medium, placed in a light incubator and cultured for 9 days, and 8mL of algal solution was taken and treated with the Trans Direct Plant Tissue PCR Kit (AD 301, Beijing Quanjin biology Co., Ltd.) (the operation method is described in the specification) to verify the PPDK transformant. Using the primers CyPPDK-F: gtttcgaatgatgccgcgaaaagacaagtg and CyPPDK-R: cacgcttctgttagtgcgccttgccattac PCR amplification, agarose gel electrophoresis, and sequencing verification to obtain mutant strains: OP-CyPPDK, and obtaining UN-CyPPDK in the same way.
(4) Phenotypic assay culture
The transformants OP-CyPPDK and UN-CyPPDK were compared with the wild type strain at the same initial OD750The cells were cultured at 22. + -. 1 ℃ for 10 days in f/2 medium under light conditions of 50. mu. mol of photons. multidot.m for the first 7 days-2·s-1The light intensity is 16h light and 8h dark, the rest 3 days are 24h light, and the light intensity is 100 mu mol photons.m-2·s-1(ii) a The used f/2 culture medium comprises the following components per liter:
1g NaNO330g of sea salt, 4.37mg of Na2EDTA,300mg Na2SiO3·7H2O,0.01mg CuSO4·5H2O,0.022mg ZnSO4·7H2O,0.01mg CoCl2·6H2O,0.18mg MnCl2·4H2O,0.006mg Na2MoO4·2H2O。
Growth curves of the transformants and the wild-type algal strains were compared as shown in FIG. 3.
(5) Measurement of EPA
Reference is made to the method of Bigogno (see literature: BIGOGNO C, KHOZIN-GOLDBERG I, BOUSSIBA S, et ale green oleaginous alga Parietochloris incisa,the richest plant source of arachidonic acid[J]Phytochemistry,2002,60(5):497-503.) oil and fat were extracted, 20mL of Phaeodactylum tricornutum cells were collected by centrifugation at 4000g, and the supernatant was discarded. 6mL of chloroform-methanol (volume ratio: 4: 2) was added, and the mixture was shaken at 37 ℃ for 1 hour. Then adding 2mL of 0.9% KCl, shaking fully, and centrifuging for 5min at 5000g to separate lipid and algae residue. Blowing dried algae oil (i.e., the above-mentioned separated lipids) was added with 1.5mL of n-hexane and 4.5mL of 2% H2SO4(dissolved in methanol), carrying out methyl esterification reaction at 85 ℃ for 3h, cooling, adding 2mL of 0.9% KCl, fully shaking, standing for 3-5 min, and taking the upper organic phase in a centrifuge tube for gas chromatography analysis.
Analysis was carried out by Agilent 7890A gas chromatography on HP-5(30 m.times.320. mu.m.times.0.25 μm). Sample inlet temperature: 250 ℃; sample introduction volume: 1 mu L of the solution; setting a temperature rise program: maintaining at 120 deg.C for 5min, then increasing to 240 deg.C at 3.5 deg.C/min, and maintaining for 10 min; the results of the EPA-fatty acid composition ratio are shown in FIG. 4.
(6) Determination of fucoxanthin
The phaeodactylum tricornutum algae cells were collected by centrifugation at 4000g, washed once with distilled water, centrifuged again and the algae cells were collected. The pigment extraction was carried out by resuspending the algal cells in absolute ethanol (ethanol: volume of algal solution 1: 1; v/v), incubating at 45 ℃ for 2 hours, shaking every half hour, and finally, separating the extracted pigment from the algal residue by centrifugation at 10000 g.
The fucoxanthin content in the extracted pigment is determined by selecting reversed phase Agilent C18 chromatographic column (2.7 μm, 100 × 4.6mm) with Hitachi high performance liquid chromatograph detection system. The detection wavelength is 445nm, the flow rate of the mobile phase is 1mL/min, and the sample injection amount is as follows: 5 μ L. The mobile phase is acetonitrile and water for gradient elution. The proportion of acetonitrile is increased from 80% to 100% within 8min, after the elution is maintained for 3min, the proportion of acetonitrile is linearly decreased to 80% within 5min, and then the concentration of acetonitrile is increased to 100% and maintained for 15 min; the results of fucoxanthin content are shown in fig. 5.
Example 2
The culture conditions are different from the culture conditions in the step (4) in the example 1 in that a high-temperature time period of 4-6 h/d at 37 ℃ is set, and the growth conditions of OP-CyPPDK, UN-CyPPDK and wild type and the contents of EPA and fucoxanthin are measured under the condition that other culture conditions are the same, so that the growth conditions of the algae strains under the high-temperature condition are generally inferior to those of the algae strains cultured under the normal condition, and the contents of EPA and fucoxanthin are relatively lower, as shown in figures 6, 7 and 8.
Examples of effects
The measured data of OP-CyPPDK, UN-CyPPDK and wild type growth, EPA and fucoxanthin contents in example 1 and example 2 are shown in tables 8 and 9
Table 8 shows the respective indices of the culture conditions in example 1
Figure BDA0002892183300000091
Table 9 shows the respective indices of the culture conditions in example 2
Figure BDA0002892183300000092
The method comprises the steps of carrying out codon optimization on exogenous CyPPDK of marine microalgae, improving the expression level of the CyPPDK, predicting possible phosphorylation sites and carrying out site-directed mutagenesis to dephosphorize the phosphorylation sites, so that the activity of the PPDK is activated, expressing the PPDK in phaeodactylum tricornutum, and improving the growth rate and the accumulation amount of bioactive substances (EPA and fucoxanthin) under the high-temperature stress condition.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and the best mode for practicing the invention, and is not intended to limit the invention in any way, so that any simple modification, equivalent change or modification made to the above embodiments according to the technical spirit of the present invention will still fall within the scope of the technical solution of the present invention without departing from the content of the technical solution of the present invention.
SEQUENCE LISTING
<110> institute of bioenergy and Process in Qingdao, China academy of sciences
<120> a mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum for producing fucoxanthin
Method
<160> 10
<170> PatentIn version 3.5
<210> 1
<211> 32
<212> DNA
<213> Artificial sequence
<400> 1
aaggcgcact aacagaagcg tgctatcgaa ct 32
<210> 2
<211> 32
<212> DNA
<213> Artificial sequence
<400> 2
ttttcgcggc atcattcgaa acggcagaca aa 32
<210> 3
<211> 30
<212> DNA
<213> Artificial sequence
<400> 3
gtttcgaatg atgccgcgaa aagacaagtg 30
<210> 4
<211> 30
<212> DNA
<213> Artificial sequence
<400> 4
cacgcttctg ttagtgcgcc ttgccattac 30
<210> 5
<211> 25
<212> DNA
<213> Artificial sequence
<400> 5
atttaggtga cactatagaa ccaga 25
<210> 6
<211> 33
<212> DNA
<213> Artificial sequence
<400> 6
gcttatcgaa attaatacga ctcactatag gga 33
<210> 7
<211> 2667
<212> DNA
<213> Artificial sequence
<400> 7
atgccccgta aggacaagtg cgtctacatg ttcgccgaag gacgtattga ccagaaggaa 60
ctcctcggaa acaagggagc caacctctgc gaaatgtccc gtctcggact ccccgtcccc 120
cccggattcg tcatcaccac caccacctgc ctcgactttt tcgaagccaa gggaaagatg 180
cccgcctccc tcaaggaaga atacattgtc gccctcgcca aggtcgaaaa gcagaccgga 240
aagaagttcg gagacaagac caaccccctc ctcctctccg tccgttccgg agccgccgtc 300
tccatgcccg gaatgatgga caccgtcctc aacctcggac tcaacgacga cattgccgcc 360
gccctcgtcg aagccaccgg aaacaagaag tgggtctacg actgctaccg tcgtctcatt 420
cagatgtacc agaacgtcgt cctcggaaag tccaccgacc cctacgaaca ggtcattaag 480
aaggtcaagg ccaccaaggg atacaagtac gatatggaac tctccggtga agactgggaa 540
tccgtcgtcg tcgaatttaa gattctctcc aagggatccc tcccctccga tccgcacgaa 600
cagctcgaaa ccgccattgc cgccgtcttt aactcctggt tcaccccccg tgccgtccgt 660
taccgtgaat acaacaacat tgaaggtctc ctcggtaccg cctgcaacgt ccagaccatg 720
gtcttcggaa acaagtccgc cgactccgga accggtgtcg ccttcacccg taaccccgcc 780
accggtgaaa acttgttctt tggtgaatac ctcgaagaag ccgaaggtga agacgtcgtc 840
tccggaatcc gcacccccca ccccctcacc tacctcaagg aaaccatgcc cgacgtctac 900
aacgaactcg acaagtccca gcgtctcctc gaaacccact tccgtgacat gcaagatctc 960
gaattctccg tcgaagaccg caccctctac atgctccaga cccgtaccgg aaagcgcacc 1020
gccaaggcct ccgtccagat tgcctgcgac atggtcgccg aaggaatgat taacgaacac 1080
gaagccctct tgcgtattga ccccgaacgt atgaactact tcctccaccc caccgtcgac 1140
accaacgccg aaaagaccgt cctcggaaag ggactccccg cctcccccgg agccgccacc 1200
ggaatggtcg tcttctgccc cgaagtcgcc gaagccaaga ttaaggccga ccccaaggtc 1260
caactcattc tcgtccgttc cgaaaccacc gccgacgaca ttcacggaat gcgtgccgcc 1320
accggtattc tcaccgaaaa cggaggaatg acctcccacg ccgccgtcgt cgcccgtgga 1380
atgggaaagt gttgcgtcgc cggagcccac aacctccacg tcgacgtcga acgtaagcaa 1440
ttcaccacca aggaaggaaa gattattaag gccggagata ttattaccct cgacggagcc 1500
accggactcg tcctcatggg agatgtcccc cgcgtccccc ccggttccga tgcctgcttc 1560
cagaccctca tgggatgggc ccgtaagtac tcccgtctcg ccgtcgccgc caacgccgat 1620
tcccccgaag acgcccgtgt cgccctctcc ttcggtgcca ccggtatcgg actctgccgt 1680
accgaacaca tgtttttccc ctccgaccgt attgacgtca tgcgtgaaat gattctcgcc 1740
gaaaccaagg aagatcgtga aaaggccctc gaccgtctct tcgtcttcca aaaggaagac 1800
atgaagggaa tgttcgaagt catgaccgga aagcacgtca ccattcgtct cctcgatccc 1860
cccctccacg aattcttgcc caccaacgtc tccgacaccg aagccctcgc cgcccgtatt 1920
ggaaagcagg tcgacgtcgt cgcccgcgaa atttccgacc tcaaggaagc caaccccatg 1980
ctcggatttc gtggttgccg cctcaccatt aagttccccg aaatcaccct catgcaggtc 2040
aaggccatta ttaccgccgc cctcgaagcc caggaaggag gagccgaagt ccaccccgaa 2100
attatgatcc cgctcattgc caccgccaag gaactcgaag ccatcgtccc cctcatggaa 2160
gccgaaattc agaaggtctt tgccgccaac ggaggaaaga ccgtccccta ccgtctcgga 2220
accatgattg aagtcccccg cgcctgcctc atcgccgaaa acattgcccc ctacgtctcc 2280
ttcatttcct tcggtaccaa cgacctcacc cagatggcct ggggattctc ccgtgatgac 2340
gtctcccact tcctccccca atacctcgaa aagaaggtcg tcaaggtcga ccccttcgtc 2400
accattgacg aagaaggagt cggtcagctc gtcaagatga ccaccgaaaa gatgaaggcc 2460
gtcaagcagg gtcagacctt taccgccgga atctgcggag aacacggagg agaccccccc 2520
tccgtctcct ttttttccaa cgtcggcctc gactacgtct cctgctcccc ctaccgtgtc 2580
cccattgcct ggattgccgc cgcccaggcc gccattaaga acggtacctc caagggatcc 2640
gtcaacggta acggtaaggc ccactaa 2667
<210> 8
<211> 888
<212> PRT
<213> Artificial sequence
<400> 8
Met Pro Arg Lys Asp Lys Cys Val Tyr Met Phe Ala Glu Gly Arg Ile
1 5 10 15
Asp Gln Lys Glu Leu Leu Gly Asn Lys Gly Ala Asn Leu Cys Glu Met
20 25 30
Ser Arg Leu Gly Leu Pro Val Pro Pro Gly Phe Val Ile Thr Thr Thr
35 40 45
Thr Cys Leu Asp Phe Phe Glu Ala Lys Gly Lys Met Pro Ala Ser Leu
50 55 60
Lys Glu Glu Tyr Ile Val Ala Leu Ala Lys Val Glu Lys Gln Thr Gly
65 70 75 80
Lys Lys Phe Gly Asp Lys Thr Asn Pro Leu Leu Leu Ser Val Arg Ser
85 90 95
Gly Ala Ala Val Ser Met Pro Gly Met Met Asp Thr Val Leu Asn Leu
100 105 110
Gly Leu Asn Asp Asp Ile Ala Ala Ala Leu Val Glu Ala Thr Gly Asn
115 120 125
Lys Lys Trp Val Tyr Asp Cys Tyr Arg Arg Leu Ile Gln Met Tyr Gln
130 135 140
Asn Val Val Leu Gly Lys Ser Thr Asp Pro Tyr Glu Gln Val Ile Lys
145 150 155 160
Lys Val Lys Ala Thr Lys Gly Tyr Lys Tyr Asp Met Glu Leu Ser Gly
165 170 175
Glu Asp Trp Glu Ser Val Val Val Glu Phe Lys Ile Leu Ser Lys Gly
180 185 190
Ser Leu Pro Ser Asp Pro His Glu Gln Leu Glu Thr Ala Ile Ala Ala
195 200 205
Val Phe Asn Ser Trp Phe Thr Pro Arg Ala Val Arg Tyr Arg Glu Tyr
210 215 220
Asn Asn Ile Glu Gly Leu Leu Gly Thr Ala Cys Asn Val Gln Thr Met
225 230 235 240
Val Phe Gly Asn Lys Ser Ala Asp Ser Gly Thr Gly Val Ala Phe Thr
245 250 255
Arg Asn Pro Ala Thr Gly Glu Asn Leu Phe Phe Gly Glu Tyr Leu Glu
260 265 270
Glu Ala Glu Gly Glu Asp Val Val Ser Gly Ile Arg Thr Pro His Pro
275 280 285
Leu Thr Tyr Leu Lys Glu Thr Met Pro Asp Val Tyr Asn Glu Leu Asp
290 295 300
Lys Ser Gln Arg Leu Leu Glu Thr His Phe Arg Asp Met Gln Asp Leu
305 310 315 320
Glu Phe Ser Val Glu Asp Arg Thr Leu Tyr Met Leu Gln Thr Arg Thr
325 330 335
Gly Lys Arg Thr Ala Lys Ala Ser Val Gln Ile Ala Cys Asp Met Val
340 345 350
Ala Glu Gly Met Ile Asn Glu His Glu Ala Leu Leu Arg Ile Asp Pro
355 360 365
Glu Arg Met Asn Tyr Phe Leu His Pro Thr Val Asp Thr Asn Ala Glu
370 375 380
Lys Thr Val Leu Gly Lys Gly Leu Pro Ala Ser Pro Gly Ala Ala Thr
385 390 395 400
Gly Met Val Val Phe Cys Pro Glu Val Ala Glu Ala Lys Ile Lys Ala
405 410 415
Asp Pro Lys Val Gln Leu Ile Leu Val Arg Ser Glu Thr Thr Ala Asp
420 425 430
Asp Ile His Gly Met Arg Ala Ala Thr Gly Ile Leu Thr Glu Asn Gly
435 440 445
Gly Met Thr Ser His Ala Ala Val Val Ala Arg Gly Met Gly Lys Cys
450 455 460
Cys Val Ala Gly Ala His Asn Leu His Val Asp Val Glu Arg Lys Gln
465 470 475 480
Phe Thr Thr Lys Glu Gly Lys Ile Ile Lys Ala Gly Asp Ile Ile Thr
485 490 495
Leu Asp Gly Ala Thr Gly Leu Val Leu Met Gly Asp Val Pro Arg Val
500 505 510
Pro Pro Gly Ser Asp Ala Cys Phe Gln Thr Leu Met Gly Trp Ala Arg
515 520 525
Lys Tyr Ser Arg Leu Ala Val Ala Ala Asn Ala Asp Ser Pro Glu Asp
530 535 540
Ala Arg Val Ala Leu Ser Phe Gly Ala Thr Gly Ile Gly Leu Cys Arg
545 550 555 560
Thr Glu His Met Phe Phe Pro Ser Asp Arg Ile Asp Val Met Arg Glu
565 570 575
Met Ile Leu Ala Glu Thr Lys Glu Asp Arg Glu Lys Ala Leu Asp Arg
580 585 590
Leu Phe Val Phe Gln Lys Glu Asp Met Lys Gly Met Phe Glu Val Met
595 600 605
Thr Gly Lys His Val Thr Ile Arg Leu Leu Asp Pro Pro Leu His Glu
610 615 620
Phe Leu Pro Thr Asn Val Ser Asp Thr Glu Ala Leu Ala Ala Arg Ile
625 630 635 640
Gly Lys Gln Val Asp Val Val Ala Arg Glu Ile Ser Asp Leu Lys Glu
645 650 655
Ala Asn Pro Met Leu Gly Phe Arg Gly Cys Arg Leu Thr Ile Lys Phe
660 665 670
Pro Glu Ile Thr Leu Met Gln Val Lys Ala Ile Ile Thr Ala Ala Leu
675 680 685
Glu Ala Gln Glu Gly Gly Ala Glu Val His Pro Glu Ile Met Ile Pro
690 695 700
Leu Ile Ala Thr Ala Lys Glu Leu Glu Ala Ile Val Pro Leu Met Glu
705 710 715 720
Ala Glu Ile Gln Lys Val Phe Ala Ala Asn Gly Gly Lys Thr Val Pro
725 730 735
Tyr Arg Leu Gly Thr Met Ile Glu Val Pro Arg Ala Cys Leu Ile Ala
740 745 750
Glu Asn Ile Ala Pro Tyr Val Ser Phe Ile Ser Phe Gly Thr Asn Asp
755 760 765
Leu Thr Gln Met Ala Trp Gly Phe Ser Arg Asp Asp Val Ser His Phe
770 775 780
Leu Pro Gln Tyr Leu Glu Lys Lys Val Val Lys Val Asp Pro Phe Val
785 790 795 800
Thr Ile Asp Glu Glu Gly Val Gly Gln Leu Val Lys Met Thr Thr Glu
805 810 815
Lys Met Lys Ala Val Lys Gln Gly Gln Thr Phe Thr Ala Gly Ile Cys
820 825 830
Gly Glu His Gly Gly Asp Pro Pro Ser Val Ser Phe Phe Ser Asn Val
835 840 845
Gly Leu Asp Tyr Val Ser Cys Ser Pro Tyr Arg Val Pro Ile Ala Trp
850 855 860
Ile Ala Ala Ala Gln Ala Ala Ile Lys Asn Gly Thr Ser Lys Gly Ser
865 870 875 880
Val Asn Gly Asn Gly Lys Ala His
885
<210> 9
<211> 888
<212> PRT
<213> Artificial sequence
<400> 9
Met Pro Arg Lys Asp Lys Cys Val Tyr Met Phe Ala Glu Gly Arg Ile
1 5 10 15
Asp Gln Lys Glu Leu Leu Gly Asn Lys Gly Ala Asn Leu Cys Glu Met
20 25 30
Ser Arg Leu Gly Leu Pro Val Pro Pro Gly Phe Val Ile Thr Thr Thr
35 40 45
Thr Cys Leu Asp Phe Phe Glu Ala Lys Gly Lys Met Pro Ala Ser Leu
50 55 60
Lys Glu Glu Tyr Ile Val Ala Leu Ala Lys Val Glu Lys Gln Thr Gly
65 70 75 80
Lys Lys Phe Gly Asp Lys Thr Asn Pro Leu Leu Leu Ser Val Arg Ser
85 90 95
Gly Ala Ala Val Ser Met Pro Gly Met Met Asp Thr Val Leu Asn Leu
100 105 110
Gly Leu Asn Asp Asp Ile Ala Ala Ala Leu Val Glu Ala Thr Gly Asn
115 120 125
Lys Lys Trp Val Tyr Asp Cys Tyr Arg Arg Leu Ile Gln Met Tyr Gln
130 135 140
Asn Val Val Leu Gly Lys Ser Thr Asp Pro Tyr Glu Gln Val Ile Lys
145 150 155 160
Lys Val Lys Ala Thr Lys Gly Tyr Lys Tyr Asp Met Glu Leu Ser Gly
165 170 175
Glu Asp Trp Glu Ser Val Val Val Glu Phe Lys Ile Leu Ser Lys Gly
180 185 190
Ser Leu Pro Ser Asp Pro His Glu Gln Leu Glu Thr Ala Ile Ala Ala
195 200 205
Val Phe Asn Ser Trp Phe Thr Pro Arg Ala Val Arg Tyr Arg Glu Tyr
210 215 220
Asn Asn Ile Glu Gly Leu Leu Gly Thr Ala Cys Asn Val Gln Thr Met
225 230 235 240
Val Phe Gly Asn Lys Ser Ala Asp Ser Gly Thr Gly Val Ala Phe Thr
245 250 255
Arg Asn Pro Ala Thr Gly Glu Asn Leu Phe Phe Gly Glu Tyr Leu Glu
260 265 270
Glu Ala Glu Gly Glu Asp Val Val Ser Gly Ile Arg Thr Pro His Pro
275 280 285
Leu Thr Tyr Leu Lys Glu Thr Met Pro Asp Val Tyr Asn Glu Leu Asp
290 295 300
Lys Ser Gln Arg Leu Leu Glu Thr His Phe Arg Asp Met Gln Asp Leu
305 310 315 320
Glu Phe Ser Val Glu Asp Arg Thr Leu Tyr Met Leu Gln Thr Arg Thr
325 330 335
Gly Lys Arg Thr Ala Lys Ala Ser Val Gln Ile Ala Cys Asp Met Val
340 345 350
Ala Glu Gly Met Ile Asn Glu His Glu Ala Leu Leu Arg Ile Asp Pro
355 360 365
Glu Arg Met Asn Tyr Phe Leu His Pro Thr Val Asp Thr Asn Ala Glu
370 375 380
Lys Thr Val Leu Gly Lys Gly Leu Pro Ala Ser Pro Gly Ala Ala Thr
385 390 395 400
Gly Met Val Val Phe Cys Pro Glu Val Ala Glu Ala Lys Ile Lys Ala
405 410 415
Asp Pro Lys Val Gln Leu Ile Leu Val Arg Ser Glu Thr Thr Ala Asp
420 425 430
Asp Ile His Gly Met Arg Ala Ala Thr Gly Ile Leu Thr Glu Asn Gly
435 440 445
Gly Met Thr Ser His Ala Ala Val Val Ala Arg Gly Met Gly Lys Cys
450 455 460
Cys Val Ala Gly Ala His Asn Leu His Val Asp Val Glu Arg Lys Gln
465 470 475 480
Phe Thr Thr Lys Glu Gly Lys Ile Ile Lys Ala Gly Asp Ile Ile Thr
485 490 495
Leu Asp Gly Ala Thr Gly Leu Val Leu Met Gly Asp Val Pro Arg Val
500 505 510
Pro Pro Gly Ser Asp Ala Cys Phe Gln Thr Leu Met Gly Trp Ala Arg
515 520 525
Lys Tyr Ser Arg Leu Ala Val Ala Ala Asn Ala Asp Ser Pro Glu Asp
530 535 540
Ala Arg Val Ala Leu Ser Phe Gly Ala Thr Gly Ile Gly Leu Cys Arg
545 550 555 560
Thr Glu His Met Phe Phe Pro Ser Asp Arg Ile Asp Val Met Arg Glu
565 570 575
Met Ile Leu Ala Glu Thr Lys Glu Asp Arg Glu Lys Ala Leu Asp Arg
580 585 590
Leu Phe Val Phe Gln Lys Glu Asp Met Lys Gly Met Phe Glu Val Met
595 600 605
Thr Gly Lys His Val Thr Ile Arg Leu Leu Asp Pro Pro Leu His Glu
610 615 620
Phe Leu Pro Thr Asn Val Ser Asp Thr Glu Ala Leu Ala Ala Arg Ile
625 630 635 640
Gly Lys Gln Val Asp Val Val Ala Arg Glu Ile Ala Asp Leu Lys Glu
645 650 655
Ala Asn Pro Met Leu Gly Phe Arg Gly Cys Arg Leu Thr Ile Lys Phe
660 665 670
Pro Glu Ile Thr Leu Met Gln Val Lys Ala Ile Ile Thr Ala Ala Leu
675 680 685
Glu Ala Gln Glu Gly Gly Ala Glu Val His Pro Glu Ile Met Ile Pro
690 695 700
Leu Ile Ala Thr Ala Lys Glu Leu Glu Ala Ile Val Pro Leu Met Glu
705 710 715 720
Ala Glu Ile Gln Lys Val Phe Ala Ala Asn Gly Gly Lys Thr Val Pro
725 730 735
Tyr Arg Leu Gly Thr Met Ile Glu Val Pro Arg Ala Cys Leu Ile Ala
740 745 750
Glu Asn Ile Ala Pro Tyr Val Ser Phe Ile Ser Phe Gly Thr Asn Asp
755 760 765
Leu Thr Gln Met Ala Trp Gly Phe Ser Arg Asp Asp Val Ser His Phe
770 775 780
Leu Pro Gln Tyr Leu Glu Lys Lys Val Val Lys Val Asp Pro Phe Val
785 790 795 800
Thr Ile Asp Glu Glu Gly Val Gly Gln Leu Val Lys Met Thr Thr Glu
805 810 815
Lys Met Lys Ala Val Lys Gln Gly Gln Thr Phe Thr Ala Gly Ile Cys
820 825 830
Gly Glu His Gly Gly Asp Pro Pro Ser Val Ser Phe Phe Ser Asn Val
835 840 845
Gly Leu Asp Tyr Val Ser Cys Ser Pro Tyr Arg Val Pro Ile Ala Trp
850 855 860
Ile Ala Ala Ala Gln Ala Ala Ile Lys Asn Gly Thr Ser Lys Gly Ser
865 870 875 880
Val Asn Gly Asn Gly Lys Ala His
885
<210> 10
<211> 2667
<212> DNA
<213> Artificial sequence
<400> 10
atgccgcgaa aagacaagtg cgtctacatg tttgccgagg gacgaatcga ccagaaggag 60
ttgctgggca ataagggcgc taatctctgt gaaatgtcgc gccttggcct tcctgtcccc 120
cccggttttg tcattaccac aaccacctgc ctcgatttct tcgaggccaa ggggaagatg 180
ccggcctctc tcaaggagga gtatatcgtc gccttggcca aggtggagaa gcagaccggc 240
aaaaaattcg gggacaagac caaccccttg cttctctccg tgcgttcagg tgcagccgtc 300
tccatgcctg gcatgatgga cacggtgctt aatctcggcc tcaatgacga cattgccgcg 360
gcgttggtag aggcaacagg caataaaaag tgggtctatg actgttaccg ccgattgatc 420
caaatgtatc aaaatgtggt gttgggcaag agcacggacc catacgaaca ggtgattaag 480
aaggtaaagg ccacaaaagg ttacaagtac gacatggagc tgagcgggga ggattgggaa 540
tcggtggtgg tggagtttaa aatactgagc aaaggaagct tgccctctga tccgcatgag 600
cagcttgaga cggccattgc ggcggttttc aattcgtggt ttacgccgcg ggcagtgcgg 660
taccgtgaat acaacaacat tgagggcctc ttggggactg cgtgcaatgt ccaaacaatg 720
gtgtttggga acaagtcggc cgattcaggc acgggggtgg ctttcacgcg caaccctgct 780
actggtgaga atttattttt tggggaatat ttggaggagg ctgagggaga ggatgtggtc 840
tcgggcatac gaaccccaca ccctttgaca tatttgaagg agaccatgcc cgatgtgtac 900
aatgagctgg ataaaagcca acggctgctg gagacgcatt tccgagacat gcaagatttg 960
gagttcagtg tcgaggaccg gacactgtac atgctccaga cccgtaccgg gaagcgcacg 1020
gctaaggcca gcgtgcagat tgcatgtgac atggtggcgg aagggatgat caacgagcat 1080
gaggccctcc tccgtatcga tcctgaacgt atgaactact tcctgcatcc cacggtggac 1140
acgaatgcgg agaagactgt cttgggaaag gggctgccgg cctcgcctgg cgccgcgaca 1200
ggaatggtag tattttgtcc tgaggtggcc gaggctaaga tcaaggcaga tcccaaagtg 1260
caacttatct tggtgcgcag tgaaacgacg gctgatgaca ttcacgggat gagggcggcg 1320
acggggattc tgaccgaaaa tggtggcatg acgagtcatg ctgctgttgt ggcccgcggg 1380
atgggaaagt gctgtgtggc tggcgcccac aatctgcacg tggacgttga gaggaagcag 1440
tttacgacga aggagggaaa aatcatcaag gccggcgata tcatcacgtt ggacggtgcc 1500
acgggcttgg tactcatggg tgatgtgcct cgcgtgcctc ctggctcgga tgcatgcttc 1560
cagacgctca tggggtgggc ccggaagtac agtcggttgg cagtggcggc gaacgcggac 1620
agtcccgagg acgcgcgtgt cgcgctttcc tttggcgcca ccggcattgg cctctgccgc 1680
acggagcaca tgtttttccc ttctgatcgc attgacgtga tgcgggagat gatattggcg 1740
gagacgaagg aagaccggga gaaggcatta gaccgcctct ttgtcttcca gaaggaggac 1800
atgaagggca tgtttgaagt aatgacgggt aagcacgtga caatccgtct attggatccg 1860
ccccttcacg aattcctccc cacgaatgtc agcgacacgg aggccctagc cgctcgcatt 1920
ggcaaacagg tggacgtagt ggcccgggaa atttctgatt tgaaggaggc gaatcccatg 1980
ctcggttttc gaggctgtcg tttgaccatt aaattcccgg agattacctt gatgcaggtc 2040
aaggccatta tcaccgccgc tctcgaagcg caggaaggcg gggcggaggt tcaccctgag 2100
attatgattc cactaattgc gacggccaag gagctggagg cgatcgttcc tttgatggaa 2160
gcggagattc agaaggtttt tgctgccaat ggcggaaaga ctgtgccata tcgtttgggg 2220
accatgattg aggtgccccg agcctgttta attgccgaaa acattgcgcc ttacgtctct 2280
ttcatctcgt ttggcaccaa cgacttgacg cagatggctt ggggattttc ccgcgatgac 2340
gtcagccact ttttgcccca gtacctggag aagaaggtcg tcaaggtcga cccctttgtc 2400
actatcgatg aagaaggtgt ggggcagcta gttaagatga ccacggagaa gatgaaggcc 2460
gtgaagcagg gccagacttt cactgccggc atttgcggtg aacacggcgg tgatccgccg 2520
agtgtctcgt tcttttctaa cgtgggcctc gattatgtct cgtgctctcc ttaccgtgtg 2580
cccattgctt ggatagcggc agctcaagcg gccatcaaga atggtacgag taagggaagc 2640
gtcaacggta atggcaaggc gcactaa 2667

Claims (12)

1. A method for constructing an overexpressed pyruvate phosphate dikinase mutant strain in phaeodactylum tricornutum is characterized by comprising the following steps of:
(1) to the originalCyPPDKThe gene is optimized by preferential codon of alga to obtain new oneCyPPDKThe gene has a nucleotide sequence shown as SEQ ID NO. 7;
(2) construction of overexpression vector of CyPPDK gene
Based on the plasmid pPha-T1, the expression vectorfcp-AAs a promoter, infcp-ADownstream of the promoter inserted into the above-obtainedPPDKGene, constructing PPDK expression vector, taking plasmid pPha-T1 as a template, utilizing primer pPha-BB-F/R, primer nucleotide sequence is shown as SEQ ID NO.1 and SEQ ID NO.2, PCR amplifying the skeleton segment required by constructing the vector; obtained by using a primer CyPPDK-F/R, the nucleotide sequence of which is shown as SEQ ID NO.3 and SEQ ID NO.4PPDKPCR amplification using the Gene as templatePPDKA gene fragment; based on the overlapping region between the PPDK fragment and the vector skeleton fragment, using a seamless ligase kit to perform fragment ligation, and designating the constructed shuttle expression vector as pPha-fcp-PPDK;
(3) preparation of transformant
Taking the expression vector pPha-fcp-PPDK constructed in the step (2) as a template, utilizing primer Trans-F/R, and primer nucleotide sequences are shown as SEQ ID NO.5 and SEQ ID NO.6, and carrying out PCR amplificationPPDKThe linearized segment of the gene and the resistance gene is introduced into the host algal cell phaeodactylum tricornutum by means of electrotransformation (Phaeodactylum tricornutum) And (4) screening the transformant in the cell to obtain a phaeodactylum tricornutum transgenic algae strain over-expressing pyruvate phosphate dikinase.
2. The method of claim 1, wherein the PCR reaction system in step (2) is as follows:
DNA template 0.5. mu.L, upstream primer 10. mu.M 1. mu.L, downstream primer 10. mu.M 1. mu.L, KAPA HiFi DNA polymerase 12.5. mu.L, ddH2O 10 μL。
3. The method of claim 2, wherein the PCR reaction conditions in step (2) are as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 98 ℃ for 20s, annealing at 15s, extension at 72 ℃ for 2000bp/min, repeating 35 cycles; extension at 72 ℃ for 5 min.
4. The method of claim 1, wherein the PCR reaction system in step (3) is as follows:
DNA template 0.5. mu.L, upstream primer 10. mu.M 1. mu.L, downstream primer 10. mu.M 1. mu.L, KAPA HiFi DNA polymerase 25. mu.L, ddH2O 22.5 μL。
5. The method of claim 4, wherein the PCR reaction conditions in step (3) are as follows:
pre-denaturation at 95 ℃ for 5 min; denaturation at 98 ℃ for 20s, annealing at 15s, extension at 72 ℃ for 2000bp/min, repeating 35 cycles; extension at 72 ℃ for 5 min.
6. The method of claim 1, wherein in step (3), the host algal cells are cultured in f/2 liquid medium to logarithmic growth phase, and collected by centrifugation and concentration (3-5) x 108(ii) individual cells; washing the algae for 4-6 times by using 375mM sorbitol, and adding 3-5 mug into the algae liquidPPDKUniformly mixing linear fragments of the gene and the resistance gene, and placing the mixture on ice to react for 10-60 minutes; adding the algae liquid after reaction into an electric rotating cup, and carrying out electric shock under the conditions of 500-1500V, 400-1000 omega and 25-100 mu F; immediately transferring the electrically shocked algae liquid to 10mL of fresh f/2 culture medium, and recovering for 24-48 hours at room temperature in a dark place; centrifuging the recovered algae liquid for 1500g and 5 minutes, discarding the supernatant, resuspending the algae liquid in a proper amount of fresh culture medium, coating the algae liquid on a f/2 resistant plate containing 5-100 mug/ml bleomycin resistance, culturing the algae liquid in an illumination incubator, and selecting transformants after 6-12 weeks.
7. The method of claim 6, wherein the positive clone is verified by PCR product sequencing by performing Direct PCR amplification operation on algal cells after genome extraction of the transformant using the Trans Direct Plant Tissue PCR Kit.
8. The method for culturing the phaeodactylum tricornutum transgenic algae strain obtained in any one of claims 1 to 7, which is characterized by comprising the following steps:
culturing the transgenic strain at 22 + -1 deg.C for 10 days under the condition of illumination of 50 μmol phosns m for the first 7 days−2·s−1The light intensity is 16h light, 8h dark, and the rest 3 days are 24h light.
9. The culture method according to claim 8, wherein the transgenic algal strain is cultured in f/2 medium.
10. Use of the transgenic strain of Phaeodactylum tricornutum obtained according to any one of claims 1 to 7 for the production of fucoxanthin and/or EPA (Eicosapentaenoic acid).
11. The application of the coding gene for expressing pyruvate phosphate dikinase in improving the yield of fucoxanthin and/or EPA (Eicosapentaenoic acid) in phaeodactylum tricornutum is disclosed, wherein the nucleotide sequence of the coding gene for expressing pyruvate phosphate dikinase is shown as SEQ ID NO. 10.
12. The use according to claim 11, wherein the pyruvate phosphate dikinase has the amino acid sequence shown in SEQ ID No. 8.
CN202110031208.XA 2021-01-11 2021-01-11 Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum Active CN112695047B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110031208.XA CN112695047B (en) 2021-01-11 2021-01-11 Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110031208.XA CN112695047B (en) 2021-01-11 2021-01-11 Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum

Publications (2)

Publication Number Publication Date
CN112695047A CN112695047A (en) 2021-04-23
CN112695047B true CN112695047B (en) 2021-11-30

Family

ID=75513852

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110031208.XA Active CN112695047B (en) 2021-01-11 2021-01-11 Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum

Country Status (1)

Country Link
CN (1) CN112695047B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113215118A (en) * 2021-05-06 2021-08-06 中国科学院青岛生物能源与过程研究所 Neoxanthin synthetase, coding gene and application thereof
CN114395571B (en) * 2022-01-21 2023-05-19 西湖大学 Phaeodactylum tricornutum ZEP1 gene, protein and application
CN115197947B (en) * 2022-05-26 2023-05-12 宁波大学 Phaeodactylum tricornutum heat shock transcription factor PtHSF1 gene and encoding protein and application thereof
CN117106592B (en) * 2023-08-18 2024-05-28 德默特生物科技(珠海)有限公司 Phaeodactylum tricornutum mutant strain and screening method of quick-growth Phaeodactylum tricornutum mutant strain
CN117106591B (en) * 2023-08-18 2024-05-10 德默特生物科技(珠海)有限公司 Method for rapidly screening mutant strain containing high fucoxanthin and Phaeodactylum tricornutum mutant strain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2441828B1 (en) * 2010-10-15 2015-02-18 Stazione Zoologica "Anton Dohrn" Algal bio-flocculation by inactivation of photoreceptors
US9868959B2 (en) * 2010-12-13 2018-01-16 J. Craig Venter Institute Engineered microalgae with enhanced lipid production
JP2017012135A (en) * 2015-07-06 2017-01-19 国立大学法人高知大学 Vector, genetically engineered marine diatom, and method for producing fucoxanthin
CN105132352A (en) * 2015-09-10 2015-12-09 宁波大学 Method for promoting accumulation of fucoxanthin and/or lipids in phaeodactylum tricornutum
US10174087B2 (en) * 2015-10-20 2019-01-08 Synthetic Genomics, Inc. Enhanced productivity by attenuation of chlorophyll binding protein genes
CN111893137B (en) * 2020-08-14 2021-07-06 中国科学院青岛生物能源与过程研究所 Method for expressing vitreoscilla hemoglobin in phaeodactylum tricornutum for autotrophic and mixotrophic culture

Also Published As

Publication number Publication date
CN112695047A (en) 2021-04-23

Similar Documents

Publication Publication Date Title
CN112695047B (en) Method for producing fucoxanthin by using mutant strain expressing exogenous pyruvate phosphate dikinase in phaeodactylum tricornutum
JP7261815B2 (en) Recombinant yeast strain producing nervonic acid and use thereof
CN114107340B (en) Mevalonate kinase gene RKMK and application thereof
JP2004500839A (en) Nutritional conversion of obligate phototrophic algae through metabolic genetic manipulation
CN115851779B (en) Glucose-6-phosphate dehydrogenase gene RkZWF1 and application thereof
JP2014527803A (en) Increased lipid content in microalgae by genetic manipulation of triacylglycerol (TAG) lipase
CN111893137B (en) Method for expressing vitreoscilla hemoglobin in phaeodactylum tricornutum for autotrophic and mixotrophic culture
CN111154665B (en) Recombinant yarrowia lipolytica and construction method and application thereof
CN110997703B (en) Novel pyruvate transferase
CN114525215B (en) Recombinant strain for producing terpenoid, construction method thereof, method for producing terpenoid through fermentation and application of recombinant strain
CN113736806B (en) Gene for improving oil synthesis of marine nannochloropsis and application thereof
WO2011069459A1 (en) Seed-specific expression vector and its construction methods and applications
CN115927445A (en) Application of OsPIL15 gene in regulation and control of water conservation and drought resistance of rice
WO2011010485A1 (en) Process for production of eicosanoid, eicosanoid biosynthesis gene derived from marchantia polymorpha, and use of the gene
CN108330114B (en) EPA-utilizing diacylglycerol acyltransferase and application thereof
CN107937362B (en) DGAT1 gene of cabbage type rape and application thereof
CN115927407B (en) Chlorella gene and application thereof in regulating growth and lipid synthesis
KR102212882B1 (en) Chlamydomonas sp. Microalgae with increased fatty acid productivity and method for increasing fatty acid productivity of Chlamydomonas sp. Microalgae
CN110904067B (en) Tobacco chlorogenic acid synthetic gene NtHQT and application thereof
CN108148849A (en) A kind of apple MdPHR1 genes and its preparation method and application
CN114644991B (en) Method for improving yeast astaxanthin yield by inactivating ubiquitin ligase and recombinant strain
CN110511919B (en) Lycopene high-yield engineering bacterium based on Dunaliella metabolic pathway and construction method and application thereof
CN109762837B (en) Method for regulating coenzyme Q synthesis by using salvia miltiorrhiza long-chain isopentenyl transferase gene SmPPS2
CN111206023A (en) Metabolic engineering method for efficiently improving content of microalgae triglyceride
CN117186197A (en) Chlorella transcription factor bZIP and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20240221

Address after: 266101 Shandong Province, Qingdao city Laoshan District Songling Road No. 189

Patentee after: Shandong Energy Research Institute

Country or region after: China

Address before: No. 189, Songling Road, Laoshan District, Qingdao City, Shandong Province 266100

Patentee before: QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES

Country or region before: China

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240527

Address after: Room 312, Building 6, No. 61 Guangsheng Road, High tech Zone, Qingdao City, Shandong Province, 266000

Patentee after: Qingdao High Energy Hecheng Biotechnology Co.,Ltd.

Country or region after: China

Address before: 266101 Shandong Province, Qingdao city Laoshan District Songling Road No. 189

Patentee before: Shandong Energy Research Institute

Country or region before: China

TR01 Transfer of patent right